Neurological Biomarkers Market Expected to Reach $18.9 Billion by 2031
Neurological biomarkers market size was valued at $5.4 billion in 2021, and is estimated to reach $18.9 billion by 2031, growing at a CAGR of 13.6% from 2022 to 2031. Ever-increasing rise in the incidence of Alzheimer's and Parkinson's is anticipated to contribute toward the robust growth of neurological biomarkers among these two applications. In addition, surge in adoption of neurological biomarkers in drug development and validation has increased over the years to improve the accuracy of clinical trials. Further, rise in transition toward personalized medicine is expected to offer profitable opportunities for the expansion of neurological biomarkers applied across Alzheimer's and Parkinson's.๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/3555
However, the sales of neurological biomarkers product have witnessed hindrances, owing to the strict government regulations. The emerging ethical issues regarding early diagnosis of Alzheimer's disease, Parkinson's disease, and multiple Sclerosis is expected to impede the market growth. On the contrary, surge in healthcare investments in public as well as private sectors, increase in focus on developing cost-effective biomarker testing increase in patient population, and rise in demand for non-invasive diagnostic techniques for Alzheimer's and Parkinson's are anticipated to open new avenues for expansion of the neurological biomarkers market size during the forecast period.
Depending on product type, the genomic segment is expected to witness a significant CAGR during the forecast period in neurological biomarkers market analysis. The major factors that contribute toward the growth of the genomic biomarkers market include increase in prevalence of neurological diseases, rise in incidence rate of ischemic stroke, high demand for minimally invasive procedures, development of technologies in clinical laboratory tests, immense developments in infrastructure for data sharing and analysis such as bioinformatics, and growing awareness about genomics biomarker-based personalized medicines. The rise in development of personalized medicines based on a specific genetic sequence of individual is projected to help propel the growth of the genomic biomarker segment in neurological biomarkers Market.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/3555
On the basis of region, Asia-Pacific is expected to witness highest CAGR during the forecast period in neurological biomarkers market forecast, owing to rise in geriatric population and the launch of various products in the region to fulfill the growing demands. Additionally, the development of human-induced pluripotent stem cells (iPS) for early diagnosis of Parkinson's disease in Japan is a recent trend, which is being followed. In addition, the rise in population in Japan is on an increase and the number has reached to 126.26 million individuals as of 2019. Therefore, such increase in population which is more susceptible to Parkinson's disease is anticipated to help supplement the neurological biomarkers industry growth.
๐๐๐ ๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐
By product type, the proteomic segment held the largest share in the neurological biomarkers market share in 2021.
By application, the Alzheimer's disease segment held the largest share in the neurological biomarkers market trends in 2021, and is expected to remain dominant during the forecast period.
By region, North America held the largest market share in neurological biomarkers industry in 2021.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarkers Market Expected to Reach $18.9 Billion by 2031 here
News-ID: 2883836 • Views: โฆ
More Releases from Allied Market Research
Aircraft Manufacturing Market Growth, Competitive Analysis, Prospects, And Top K โฆ
Favorable government initiatives, the surge in the demand for air travel, and technological advancements in aircraft manufacturing drive the growth of the global ๐๐ข๐ซ๐๐ซ๐๐๐ญ ๐๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ. The global aircraft manufacturing market size was valued at $296.6 billion in 2021, and is projected to reach $476.4 billion by 2031, growing at a CAGR of 5% from 2022 to 2031.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐๐จ๐ฐ: https://www.alliedmarketresearch.com/request-sample/A53658
Aircraft manufacturing is the process of building aircrafts toโฆ
Hydraulic Equipment Market Size, Scope and Comprehensive Analysis by 2027
Hydraulic equipment operate by utilizing liquid fluid as their working medium, where hydraulic liquid is pumped into the machine and pressurized to overcome resistance encountered by cylinders and motors. The flow of liquids is regulated by valves, and the liquid is then distributed through pipes, hoses, or tubes. These equipment are characterized by their ease of operation, safety, and reliability, even under varying speeds.
The surge in mechanized agricultural practicesโฆ
Pipes Market By Leading Key Players Projected to Reach $209.1 billion by 2032
Materials commonly utilized for pipe manufacturing include metal, thermoplastic, concrete, and thermoset & composite materials. In 2022, the metal pipes segment dominated the market in revenue terms, driven by their widespread adoption in industrial and large-scale applications within the water & wastewater, and oil & gas sectors. However, the thermoplastic pipes segment is anticipated to exhibit a higher compound annual growth rate (CAGR) during the forecast period due to increasedโฆ
Automotive Ceramics Market Opportunities, Strategies, Size, Share And Analysis 2 โฆ
The global automotive ceramics industry, as outlined in the report by Allied Market Research, reached $1.9 billion in 2019 and is anticipated to hit $3.1 billion by 2027, boasting a Compound Annual Growth Rate (CAGR) of 6.5% from 2020 to 2027. The report delves into comprehensive analysis, covering evolving market trends, winning strategies, key segments, Porter's Five Forces, and the business performance of major market players.
The market's growth is propelledโฆ
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provideโฆ
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Globalโฆ
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a โฆ
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life whenโฆ
PARKINSON RESEARCH FOUNDATIONโS (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU โฆ
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRFโs ventured to the Western Caribbean on its mostโฆ
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRFโs focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundationโs educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affectedโฆ
Parkinson`s Disease:New Hope Educational Conference
PARKINSONโS DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinsonโs conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinsonโs disease and movement disorders. He has an extensive background andโฆ